Insider · CIK 0001220630
Joel Ackerman
directorcfoofficer
Files at CSBR (CHAMPIONS ONCOLOGY, INC.), DVA (DAVITA INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 15, 2025 | DVA DAVITA INC. | AGrant or award Common Stock | +5,995 | $0.00 | $0 | 148,064 | Mar 18, 2025 |
| Mar 15, 2025 | DVA DAVITA INC. | FTax withholding Common Stock | -3,093 | $143.45 | $444k | 144,971 | Mar 18, 2025 |
| Mar 15, 2025 | DVA DAVITA INC. | FTax withholding Common Stock | -3,331 | $143.45 | $478k | 141,640 | Mar 18, 2025 |
| Mar 15, 2025 | DVA DAVITA INC. | AGrant or award Stock Appreciation Rightsderivative | +16,597 | $0.00 | $0 | 16,597 | Mar 18, 2025 |
| Mar 12, 2025 | DVA DAVITA INC. | AGrant or award Common Stock | +7,394 | $0.00 | $0 | 134,848 | Mar 14, 2025 |
| Mar 12, 2025 | DVA DAVITA INC. | AGrant or award Common Stock | +7,221 | $0.00 | $0 | 142,069 | Mar 14, 2025 |
| Nov 12, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | AGrant or award Option to purchase Common Stockderivative | +43,190 | $4.64 | $200k | 43,190 | Nov 18, 2024 |
| Oct 31, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | MOption exercise Common Stock | +88,470 | $2.10 | $186k | 945,467 | Nov 1, 2024 |
| Oct 31, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | MOption exercise Common Stock | +16,667 | $5.43 | $91k | 962,134 | Nov 1, 2024 |
| Oct 31, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | MOption exercise Option to purchase Common Stockderivative | -88,470 | $2.10 | $186k | 0 | Nov 1, 2024 |
| Oct 31, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | MOption exercise Option to purchase Common Stockderivative | -16,667 | $5.43 | $91k | 0 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.